BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7689489)

  • 1. Rising tumour marker during chemotherapy in a patient with an extra-gonadal germ cell tumour--prolonged survival after tumour excision.
    Abratt RP; Ponton AR; Taylor DA
    Eur J Surg Oncol; 1993 Aug; 19(4):381-4. PubMed ID: 7689489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retroperitoneal germ cell tumors with high level of serum and urine hCG in an adult: a case report].
    Nakajima Y; Nakamura S; Kimura S; Kuramochi S; Nakamura K
    Hinyokika Kiyo; 1989 Feb; 35(2):301-5. PubMed ID: 2472050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of malignant mediastinal nonseminomatous germ cell tumor.
    Kang CH; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Feb; 85(2):379-84. PubMed ID: 18222229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
    Ramani VA; Grey BR; Addla SK; Dunham MP; Sangar VK; Clarke NW
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone.
    Coogan CL; Foster RS; Rowland RG; Bihrle R; Smith ER; Einhorn LH; Roth BJ; Donohue JP
    Urology; 1997 Dec; 50(6):957-62. PubMed ID: 9426730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: indications, histopathology and outcome.
    Ong TA; Winkler MH; Savage PM; Seckl MJ; Christmas TJ
    BJU Int; 2008 Jul; 102(2):198-202. PubMed ID: 18294302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal intradural primary germ cell tumour--review of literature and case report.
    Biswas A; Puri T; Goyal S; Gupta R; Eesa M; Julka PK; Rath GK
    Acta Neurochir (Wien); 2009 Mar; 151(3):277-84. PubMed ID: 19240975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroperitoneal metastatic squamous cell carcinoma of the tonsil (with elevated beta human chorionic gonadotrophin): a misdiagnosis as extra-gonadal germ cell tumour.
    Hofmann U; O'Connor JP; Biyani CS; Harnden P; Selby P; Weston PM
    J Laryngol Otol; 2006 Oct; 120(10):885-7. PubMed ID: 16716237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
    Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
    J Clin Oncol; 2005 Sep; 23(25):6149-56. PubMed ID: 16135481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours.
    Horvath LG; McCaughan BC; Stockle M; Boyer MJ
    Intern Med J; 2002 Mar; 32(3):79-83. PubMed ID: 11885847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Germ cell testicular tumors: understanding the kinetics of serum human chorionic gonadotropin during chemotherapy].
    Riedinger JM; Eche N; Fargeot P
    Ann Biol Clin (Paris); 2008; 66(5):515-21. PubMed ID: 18957340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer.
    Schneider BP; Kesler KA; Brooks JA; Yiannoutsos C; Einhorn LH
    J Clin Oncol; 2004 Apr; 22(7):1195-200. PubMed ID: 15051766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Observation policy for residual masses after chemotherapy for gonadal and extra-gonadal germ cell tumors].
    Takizawa A; Miura T; Fujinami K; Osada Y
    Hinyokika Kiyo; 2005 Apr; 51(4):247-51. PubMed ID: 15912783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
    Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
    Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retroperitoneal extragonadal germinal choriocarcinoma: description of a case and the complex therapeutic approach].
    Lindenmeir T; Giacchi S; Wullich B; Zwergel T
    Ann Urol (Paris); 1996; 30(2):94-8. PubMed ID: 8767815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
    Motzer RJ; Nichols CJ; Margolin KA; Bacik J; Richardson PG; Vogelzang NJ; Bajorin DF; Lara PN; Einhorn L; Mazumdar M; Bosl GJ
    J Clin Oncol; 2007 Jan; 25(3):247-56. PubMed ID: 17235042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.